TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Next Generation Cancer Diagnostics Market Report & Forecast 2022-2028

Global and United States Next Generation Cancer Diagnostics Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 12 October 2022
  • Pages :114
  • Formats:
  • Report Code:SMR-7433401
OfferClick for best price

Best Price: $3480

Next Generation Cancer Diagnostics Market Size, Share 2022


Market Analysis and Insights: Global Next Generation Cancer Diagnostics Market

The global Next Generation Cancer Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Cancer Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Cancer Diagnostics market.

Global Next Generation Cancer Diagnostics Scope and Market Size

Next Generation Cancer Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Next Generation Cancer Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Segment by Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

By Company

  • Cepheid
  • Koninklijke Philips N.V
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • Novartis AG
  • Abbott
  • Thermo Fisher Scientific
  • Opko Health
  • Myriad Genetics
  • Agilent Technologies
  • GE Healthcare
  • PerkinElmer
  • Genomic Health
  • Illumina
  • Hologic
  • Almac Group
  • Janssen Global Services
  • Sysmex Corporation

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Next Generation Cancer Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Next Generation Cancer Diagnostics, with price, sales, revenue, and global market share of Next Generation Cancer Diagnostics from 2019 to 2022.

Chapter 3, the Next Generation Cancer Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Next Generation Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Next Generation Cancer Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Cancer Diagnostics.

Chapter 13, 14, and 15, to describe Next Generation Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Next Generation Cancer Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Next Generation Cancer Diagnostics Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 114 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Next Generation Cancer Diagnostics Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Next Generation Cancer Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Next Generation Cancer Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Next Generation Cancer Diagnostics Market Size for the Year 2017-2028
1.3 Next Generation Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Next Generation Cancer Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Next Generation Cancer Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Next Generation Cancer Diagnostics Market Dynamics
1.4.1 Next Generation Cancer Diagnostics Industry Trends
1.4.2 Next Generation Cancer Diagnostics Market Drivers
1.4.3 Next Generation Cancer Diagnostics Market Challenges
1.4.4 Next Generation Cancer Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Next Generation Cancer Diagnostics by Type
2.1 Next Generation Cancer Diagnostics Market Segment by Type
2.1.1 Next Generation Sequencing
2.1.2 qPCR & Multiplexing
2.1.3 DNA Microarrays
2.1.4 Others
2.2 Global Next Generation Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Next Generation Cancer Diagnostics Market Size by Type (2017-2028)
2.4 United States Next Generation Cancer Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Next Generation Cancer Diagnostics Market Size by Type (2017-2028)
3 Next Generation Cancer Diagnostics by Application
3.1 Next Generation Cancer Diagnostics Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Next Generation Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Next Generation Cancer Diagnostics Market Size by Application (2017-2028)
3.4 United States Next Generation Cancer Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Next Generation Cancer Diagnostics Market Size by Application (2017-2028)
4 Global Next Generation Cancer Diagnostics Competitor Landscape by Company
4.1 Global Next Generation Cancer Diagnostics Market Size by Company
4.1.1 Top Global Next Generation Cancer Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Next Generation Cancer Diagnostics Revenue by Player (2017-2022)
4.2 Global Next Generation Cancer Diagnostics Concentration Ratio (CR)
4.2.1 Next Generation Cancer Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Next Generation Cancer Diagnostics in 2021
4.2.3 Global Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Next Generation Cancer Diagnostics Headquarters, Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Next Generation Cancer Diagnostics Headquarters and Area Served
4.3.2 Global Next Generation Cancer Diagnostics Companies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Next Generation Cancer Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Next Generation Cancer Diagnostics Market Size by Company
4.5.1 Top Next Generation Cancer Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Next Generation Cancer Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Next Generation Cancer Diagnostics Market Size by Region
5.1 Global Next Generation Cancer Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Next Generation Cancer Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Next Generation Cancer Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Next Generation Cancer Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Next Generation Cancer Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Next Generation Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Next Generation Cancer Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Next Generation Cancer Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Next Generation Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Next Generation Cancer Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Next Generation Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Next Generation Cancer Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Next Generation Cancer Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Cepheid
7.1.1 Cepheid Company Details
7.1.2 Cepheid Business Overview
7.1.3 Cepheid Next Generation Cancer Diagnostics Introduction
7.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.1.5 Cepheid Recent Development
7.2 Koninklijke Philips N.V
7.2.1 Koninklijke Philips N.V Company Details
7.2.2 Koninklijke Philips N.V Business Overview
7.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Introduction
7.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.2.5 Koninklijke Philips N.V Recent Development
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Details
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Introduction
7.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.3.5 F. Hoffmann-La Roche Ltd Recent Development
7.4 Qiagen
7.4.1 Qiagen Company Details
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Next Generation Cancer Diagnostics Introduction
7.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.4.5 Qiagen Recent Development
7.5 Novartis AG
7.5.1 Novartis AG Company Details
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Next Generation Cancer Diagnostics Introduction
7.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.5.5 Novartis AG Recent Development
7.6 Abbott
7.6.1 Abbott Company Details
7.6.2 Abbott Business Overview
7.6.3 Abbott Next Generation Cancer Diagnostics Introduction
7.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.6.5 Abbott Recent Development
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Details
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Introduction
7.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.7.5 Thermo Fisher Scientific Recent Development
7.8 Opko Health
7.8.1 Opko Health Company Details
7.8.2 Opko Health Business Overview
7.8.3 Opko Health Next Generation Cancer Diagnostics Introduction
7.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.8.5 Opko Health Recent Development
7.9 Myriad Genetics
7.9.1 Myriad Genetics Company Details
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics Next Generation Cancer Diagnostics Introduction
7.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.9.5 Myriad Genetics Recent Development
7.10 Agilent Technologies
7.10.1 Agilent Technologies Company Details
7.10.2 Agilent Technologies Business Overview
7.10.3 Agilent Technologies Next Generation Cancer Diagnostics Introduction
7.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.10.5 Agilent Technologies Recent Development
7.11 GE Healthcare
7.11.1 GE Healthcare Company Details
7.11.2 GE Healthcare Business Overview
7.11.3 GE Healthcare Next Generation Cancer Diagnostics Introduction
7.11.4 GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.11.5 GE Healthcare Recent Development
7.12 PerkinElmer
7.12.1 PerkinElmer Company Details
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Next Generation Cancer Diagnostics Introduction
7.12.4 PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.12.5 PerkinElmer Recent Development
7.13 Genomic Health
7.13.1 Genomic Health Company Details
7.13.2 Genomic Health Business Overview
7.13.3 Genomic Health Next Generation Cancer Diagnostics Introduction
7.13.4 Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.13.5 Genomic Health Recent Development
7.14 Illumina
7.14.1 Illumina Company Details
7.14.2 Illumina Business Overview
7.14.3 Illumina Next Generation Cancer Diagnostics Introduction
7.14.4 Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.14.5 Illumina Recent Development
7.15 Hologic
7.15.1 Hologic Company Details
7.15.2 Hologic Business Overview
7.15.3 Hologic Next Generation Cancer Diagnostics Introduction
7.15.4 Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.15.5 Hologic Recent Development
7.16 Almac Group
7.16.1 Almac Group Company Details
7.16.2 Almac Group Business Overview
7.16.3 Almac Group Next Generation Cancer Diagnostics Introduction
7.16.4 Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.16.5 Almac Group Recent Development
7.17 Janssen Global Services
7.17.1 Janssen Global Services Company Details
7.17.2 Janssen Global Services Business Overview
7.17.3 Janssen Global Services Next Generation Cancer Diagnostics Introduction
7.17.4 Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.17.5 Janssen Global Services Recent Development
7.18 Sysmex Corporation
7.18.1 Sysmex Corporation Company Details
7.18.2 Sysmex Corporation Business Overview
7.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Introduction
7.18.4 Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
7.18.5 Sysmex Corporation Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Next Generation Cancer Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Next Generation Cancer Diagnostics Market Trends
Table 3. Next Generation Cancer Diagnostics Market Drivers
Table 4. Next Generation Cancer Diagnostics Market Challenges
Table 5. Next Generation Cancer Diagnostics Market Restraints
Table 6. Global Next Generation Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Next Generation Cancer Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Next Generation Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Next Generation Cancer Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Next Generation Cancer Diagnostics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Next Generation Cancer Diagnostics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Next Generation Cancer Diagnostics Revenue Share by Player, 2017-2022
Table 13. Global Next Generation Cancer Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)
Table 15. Top Players of Next Generation Cancer Diagnostics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Next Generation Cancer Diagnostics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Next Generation Cancer Diagnostics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Next Generation Cancer Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Next Generation Cancer Diagnostics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Next Generation Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Next Generation Cancer Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Next Generation Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Next Generation Cancer Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Next Generation Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Next Generation Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Next Generation Cancer Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Cepheid Company Details
Table 31. Cepheid Business Overview
Table 32. Cepheid Next Generation Cancer Diagnostics Product
Table 33. Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 34. Cepheid Recent Development
Table 35. Koninklijke Philips N.V Company Details
Table 36. Koninklijke Philips N.V Business Overview
Table 37. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product
Table 38. Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 39. Koninklijke Philips N.V Recent Development
Table 40. F. Hoffmann-La Roche Ltd Company Details
Table 41. F. Hoffmann-La Roche Ltd Business Overview
Table 42. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product
Table 43. F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 44. F. Hoffmann-La Roche Ltd Recent Development
Table 45. Qiagen Company Details
Table 46. Qiagen Business Overview
Table 47. Qiagen Next Generation Cancer Diagnostics Product
Table 48. Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 49. Qiagen Recent Development
Table 50. Novartis AG Company Details
Table 51. Novartis AG Business Overview
Table 52. Novartis AG Next Generation Cancer Diagnostics Product
Table 53. Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 54. Novartis AG Recent Development
Table 55. Abbott Company Details
Table 56. Abbott Business Overview
Table 57. Abbott Next Generation Cancer Diagnostics Product
Table 58. Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 59. Abbott Recent Development
Table 60. Thermo Fisher Scientific Company Details
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product
Table 63. Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. Opko Health Company Details
Table 66. Opko Health Business Overview
Table 67. Opko Health Next Generation Cancer Diagnostics Product
Table 68. Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 69. Opko Health Recent Development
Table 70. Myriad Genetics Company Details
Table 71. Myriad Genetics Business Overview
Table 72. Myriad Genetics Next Generation Cancer Diagnostics Product
Table 73. Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 74. Myriad Genetics Recent Development
Table 75. Agilent Technologies Company Details
Table 76. Agilent Technologies Business Overview
Table 77. Agilent Technologies Next Generation Cancer Diagnostics Product
Table 78. Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 79. Agilent Technologies Recent Development
Table 80. GE Healthcare Company Details
Table 81. GE Healthcare Business Overview
Table 82. GE Healthcare Next Generation Cancer Diagnostics Product
Table 83. GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 84. GE Healthcare Recent Development
Table 85. PerkinElmer Company Details
Table 86. PerkinElmer Business Overview
Table 87. PerkinElmer Next Generation Cancer Diagnostics Product
Table 88. PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 89. PerkinElmer Recent Development
Table 90. Genomic Health Company Details
Table 91. Genomic Health Business Overview
Table 92. Genomic Health Next Generation Cancer Diagnostics Product
Table 93. Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 94. Genomic Health Recent Development
Table 95. Illumina Company Details
Table 96. Illumina Business Overview
Table 97. Illumina Next Generation Cancer Diagnostics Product
Table 98. Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 99. Illumina Recent Development
Table 100. Hologic Company Details
Table 101. Hologic Business Overview
Table 102. Hologic Next Generation Cancer Diagnostics Product
Table 103. Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 104. Hologic Recent Development
Table 105. Almac Group Company Details
Table 106. Almac Group Business Overview
Table 107. Almac Group Next Generation Cancer Diagnostics Product
Table 108. Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 109. Almac Group Recent Development
Table 110. Janssen Global Services Company Details
Table 111. Janssen Global Services Business Overview
Table 112. Janssen Global Services Next Generation Cancer Diagnostics Product
Table 113. Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 114. Janssen Global Services Recent Development
Table 115. Sysmex Corporation Company Details
Table 116. Sysmex Corporation Business Overview
Table 117. Sysmex Corporation Next Generation Cancer Diagnostics Product
Table 118. Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 119. Sysmex Corporation Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Next Generation Cancer Diagnostics Product Picture
Figure 2. Global Next Generation Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Next Generation Cancer Diagnostics Market Size 2017-2028 (US$ Million)
Figure 4. United States Next Generation Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Next Generation Cancer Diagnostics Market Size 2017-2028 (US$ Million)
Figure 6. United States Next Generation Cancer Diagnostics Market Share in Global 2017-2028
Figure 7. Next Generation Cancer Diagnostics Report Years Considered
Figure 8. Product Picture of Next Generation Sequencing
Figure 9. Product Picture of qPCR & Multiplexing
Figure 10. Product Picture of DNA Microarrays
Figure 11. Product Picture of Others
Figure 12. Global Next Generation Cancer Diagnostics Market Share by Type in 2022 & 2028
Figure 13. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
Figure 15. United States Next Generation Cancer Diagnostics Market Share by Type in 2022 & 2028
Figure 16. United States Next Generation Cancer Diagnostics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
Figure 18. Product Picture of Hospitals
Figure 19. Product Picture of Clinics
Figure 20. Product Picture of Others
Figure 21. Global Next Generation Cancer Diagnostics Market Share by Application in 2022 & 2028
Figure 22. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
Figure 24. United States Next Generation Cancer Diagnostics Market Share by Application in 2022 & 2028
Figure 25. United States Next Generation Cancer Diagnostics Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
Figure 27. North America Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Next Generation Cancer Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 56. Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 58. Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 59. Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 60. Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 62. Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 63. Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 64. Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 65. GE Healthcare Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 66. PerkinElmer Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 67. Genomic Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 68. Illumina Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 69. Hologic Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 70. Almac Group Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 71. Janssen Global Services Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 72. Sysmex Corporation Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount